Join us for our May 13 webinar on How to Develop Fit-for-Purpose Quantitative IHC Assays to Enable Clinical Trial Patient Stratification. Dr. Sharon Moulis will be presenting how traditional methods of IHC assay design can be modified with...

April 16, 2015, Westminster CO — Flagship Biosciences, the leading service provider of digital pathology solutions, announced today the utilization of its wet assay development and image analysis quantification capabilities for RNAscope®...

Extracting meaningful information from intact tissue is becoming ever more critical as researchers look for better ways to characterize molecular activity of cells within their native micro-environments. With PerkinElmer’s new inForm®...

Westminster, CO – April 5, 2015 – Since 2009, Flagship Biosciences has grown to become recognized as the clear industry leader in the delivery of precision pathology reports quantifying a given endpoint in digital pathology. These reports...

Software brings image analysis and big data capabilities to help researchers, clinicians and hospitals collaborate to fight cancer Baltimore, MD (PRWEB) March 25, 2015  - Proscia, a medical technology start-up that is dedicated to bringing...

After thorough testing, and internal clinical validation, Herlev University Hospital selects Visiopharm’s ONCOtopix™ Dx – a platform for computer assisted quantitative diagnostic immunohistochemistry (IHC) and In-Situ Hybridization...